Nucleic acid amplification technologies are used for the rapid and accurate diagnosis of chronic and infectious diseases. The nucleic acid amplification is one of the important tool for wide aspects of life science technologies including, clinical medicine development, diagnosis of infectious diseases, and gene cloning.
This report contains market size and forecasts of Nucleic Acid Amplification Detection and Diagnostics in Global, including the following market information:
Global Nucleic Acid Amplification Detection and Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Nucleic Acid Amplification Detection and Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Polymerase Chain Reaction (PCR) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nucleic Acid Amplification Detection and Diagnostics include BD, BioMerieux SA, BIO-RAD LABORATORIES INC., THERMO FISHER SCIENTIFIC INC., Illumina, Inc., Danaher, QIAGEN, Abbott and Meridian Bioscience, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nucleic Acid Amplification Detection and Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nucleic Acid Amplification Detection and Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Nucleic Acid Amplification Detection and Diagnostics Market Segment Percentages, by Type, 2021 (%)
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Isothermal Amplification Technology
Direct Nucleic Acid Detection
CRISPR-Cas9
Global Nucleic Acid Amplification Detection and Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Nucleic Acid Amplification Detection and Diagnostics Market Segment Percentages, by Application, 2021 (%)
Hospital and Clinics
Diagnostic Centers
Research Institutes
Others
Global Nucleic Acid Amplification Detection and Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Nucleic Acid Amplification Detection and Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nucleic Acid Amplification Detection and Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Nucleic Acid Amplification Detection and Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BD
BioMerieux SA
BIO-RAD LABORATORIES INC.
THERMO FISHER SCIENTIFIC INC.
Illumina, Inc.
Danaher
QIAGEN
Abbott
Meridian Bioscience, Inc.
F. Hoffmann-La Roche Ltd.
PreAnalytiX
Eiken Chemical
Lucigen
OptiGene
NEB
Quidel Corporation
Promega
Hologic
Ustar
Grifols
Nugen